The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,908.00
Bid: 1,908.00
Ask: 1,909.00
Change: 3.00 (0.16%)
Spread: 1.00 (0.052%)
Open: 1,916.00
High: 1,927.00
Low: 1,903.00
Prev. Close: 1,905.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: London Seen Lower Ahead Of ECB And BoE Rate Decisions

Thu, 05th Mar 2015 07:01

LONDON (Alliance News) - London shares are set to open lower Thursday, as investors look forward to ECB President Mario Draghi outlining details of the central bank's planned government bond-buying programme, while also awaiting the Bank of England's rate decision announcement.

"On the subject of stimulus, the focus today will be on two central banks, the Bank of England, who are expected to do keep rates unchanged for the 72nd month in a row, and the ECB who are having their latest meeting in Cyprus", says Michael Hewson, chief market analyst at CMC Markets.

"The main focus will be on not only the form of assets the ECB intends to buy, but also on the updating of the growth and inflation forecasts, as these could give clues as to the timeframe of any QE program," Hewson writes.

China's Premier Li Keqiang on Thursday lowered the growth target for China this year to "approximately 7%." Li's speech outlined a government work report on the country's key economic policies for this year. He said China faces challenges including sluggish investment growth, falling prices on manufactured products and an "inefficient" growth model, coupled with problems of overcapacity and lack of innovation.

IG futures indicate the FTSE 100 to open 12 points lower at 6,907.5. The index closed up 0.4% at 6,919.24 on Wednesday, after a late rally that was emulated in Europe's main equity indices, snapping a three-day losing streak amid a continued focus on full-year earnings from a large number of companies, including ITV and Standard Chartered.

Also Wednesday FTSE confirmed Hikma Pharma replacing Tullow Oil in FTSE 100, while said AA, Virgin Money and Imagination Technologies will replace Afren, GAME Digital and Oxford Instruments. These changes will take effect from the market open on Monday, March 23, following completion of its quarterly review.

Wall Street ended lower Wednesday. The DJIA closed down 0.6%, the S&P 500 ended down 0.4% and the Nasdaq Composite finished down 0.3%.

In Asia on Thursday, the Japanese Nikkei 225 closed up 0.3%, and the Hang Seng trades down 1.1%. The Shanghai Composite is trading down 1.1%.

Brent crude is quoted at around USD60.64 a barrel Thursday, and US benchmark West Texas Intermediate is quoted at USD51.83 a barrel. Gold is quoted early Thursday at USD1,202.59 an ounce.

In the corporate calendar Thursday, Aggreko, Schroders, Aviva, London Stock Exchange Group, Friends Life Group, Inmarsat, CSR, H&T Group, Cobham, Admiral Group, Spirax-Sarco Engineering and Hunting release full-year results. Betfair Group issues an interim management statement. Easyjet gives its traffic statistics for February.

In the economic calendar, German factory orders are at 0700 GMT, while Italy's GDP is at 0900 GMT. The Bank of England releases its interest rate decision at 1200 GMT, while the ECB follows at 1245 GMT. In the US, initial jobless claims data is at 1330 GMT, while factory orders are at 1500 GMT.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
30 Apr 2021 07:57

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

Read more
30 Apr 2021 07:38

Hikma predicts generics revenue at top of guidance

(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.

Read more
23 Apr 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Apr 2021 12:08

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more
21 Apr 2021 09:01

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

Read more
21 Apr 2021 07:52

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

Read more
21 Apr 2021 07:30

Hikma resumes US launch of 'Advair Diskus' generic

(Sharecast News) - Hikma Pharmaceuticals has resumed the launch of its generic version of GlaxoSmithKline's 'Advair Diskus' in the United States, it announced on Wednesday, following Food and Drug Administration (FDA) approval of an amendment it submitted to its Abbreviated New Drug Application in January.

Read more
19 Apr 2021 16:02

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
16 Apr 2021 14:54

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
31 Mar 2021 17:04

LONDON MARKET CLOSE: Stocks end lower; investors shun Deliveroo

LONDON MARKET CLOSE: Stocks end lower; investors shun Deliveroo

Read more
31 Mar 2021 13:40

Wednesday broker round-up

(Sharecast News) - Hikma: Jefferies upgrades to buy with a target price of 2,870p.

Read more
31 Mar 2021 12:17

LONDON MARKET MIDDAY: Biden spends big; Deliveroo dives on debut

LONDON MARKET MIDDAY: Biden spends big; Deliveroo dives on debut

Read more
31 Mar 2021 11:56

Jefferies upgrades Hikma to 'buy'

(Sharecast News) - Analysts at Jefferies upgraded drugmaker Hikma Pharmaceuticals from 'hold' to 'buy' on Wednesday, stating the group's share price was yet to reflect "a series of upcoming product catalysts".

Read more
31 Mar 2021 09:37

BROKER RATINGS: BP cut by Morgan Stanley; Jefferies raises Hikma

BROKER RATINGS: BP cut by Morgan Stanley; Jefferies raises Hikma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.